Researchers have found in a cohort study that patients with atrial fibrillation (AF) receiving a factor Xa inhibitor and ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

Adapted with permission from [9,21]. Events Rivaroxaban (number per 100 patient years) Warfarin (number per 100 patient years) Rivaroxaban versus warfarin hazard ratio (95% CI) Primary safety ...

Background: A potential drug interaction exists between oral corticosteroids and warfarin, but there is limited documentation. Objective: To evaluate the potential drug interaction between oral ...

This leaflet answers some common questions about COSAMIDE 50. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...

The RCT found edoxaban was non-inferior to warfarin for thromboembolic outcomes, but not for bleeding. Substantial methodological and clinical heterogeneity, high risk of bias and insufficient ...

Exposure to high levels of aircraft noise, especially at night, is associated with adverse cardiac remodeling in the form of concentric left ventricular (LV) hypertrophy and reduced LV systolic ...